Single Fraction of HDR Brachytherapy Found Effective in Localized Prostate Cancer March 23, 2017 Results from a prospective clinical trial suggest a single, 19-Gray (Gy) high-dose–rate (HDR) of brachytherapy is a safe and effective option over longer courses of HDR therapy for patients with localized prostate cancer.Read more.Source: Oncology Nurse Advisor Prostate Cancer News
Results from a prospective clinical trial suggest a single, 19-Gray (Gy) high-dose–rate (HDR) of brachytherapy is a safe and effective option over longer courses of HDR therapy for patients with localized prostate cancer.Read more.Source: Oncology Nurse Advisor
Donate Now
